SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000897069-23-001848
Filing Date
2023-12-27
Accepted
2023-12-27 17:27:24
Documents
2
Group Members
MCNULTY BRIAN PATRICK

Document Format Files

Seq Description Document Type Size
1 mcnultybayshore13da122723.htm SC 13D/A 83078
2 image0.jpg GRAPHIC 46993
  Complete submission text file 0000897069-23-001848.txt   149487
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Subject) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: SC 13D/A | Act: 34 | File No.: 005-94142 | Film No.: 231518887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173 (737) 289-0835
Bay Shore Trust (Filed by) CIK: 0001986593 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A